V20MAX
V20MAX, licence 80053999: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Performance Plus
- Licence holder
- 1964933 Ontario Inc. o/a Canadian All Natural
- NPN or DIN-HM
- 80053999
- Status
- Inactive licence
- Licence date
- 17 September 2014
- Revision date
- 3 May 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Panax ginseng - racine Extraction ratio : 5:1 Dry plant equivalent : 500 mg | 100.0 mg | Not calculated |
| Epimedium brevicornu Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 1300 mg | 130.0 mg | Not calculated |
| Ophiocordyceps sinensis Source : Ophiocordyceps sinensis - mycelia | 120.0 mg | Not calculated |
| Lepidium meyenii Source : Lepidium meyenii - racine Extraction ratio : 15:1 Dry plant equivalent : 1500 mg | 100.0 mg | Not calculated |
| Cinnamomum aromaticum Source : Cinnamomum aromaticum - Écorce de branche Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Panax ginseng is used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Panax ginseng is used in Herbal Medicine to help(s) support cognitive function and/or reduce mental fatigue (in cases of mental stress). Panax ginseng is used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress). Provides antioxidants. Cassia is traditionally used in Herbal Medicine for digestive disturbances/dyspeptic complaints/indigestion, such as mild spasms of the gastrointestinal tract, bloating and flatulence. Cassia is traditionally used in Herbal Medicine for loss of appetite. Maca helps to support emotional aspects of sexual health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053999
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.